Knowledge of Infectious Disease Specialists Regarding Aspergillosis Complicating Influenza, United States

Insights

Nearly one-fifth of US physicians encountered invasive pulmonary aspergillosis post-influenza. Routine use of galactomannan testing for this fungal infection remains low, despite its potential diagnostic value.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Pulmonology

Background:

  • Severe influenza infections can predispose patients to secondary fungal pneumonias.
  • Invasive pulmonary aspergillosis (IPA) is a serious opportunistic infection.
  • Early diagnosis of IPA is crucial for patient outcomes.

Observation:

  • An online survey revealed that approximately 20% of responding US physicians had encountered IPA cases following severe influenza.
  • Physicians reported awareness of IPA in severe influenza cases at their institutions.

Findings:

  • Despite the observed incidence of IPA post-influenza, less than 10% of physicians routinely employed galactomannan testing for diagnosis.
  • There is a significant gap between the recognition of IPA and its diagnostic workup in severe influenza patients.

Implications:

  • This suggests underutilization of a key diagnostic biomarker for IPA in a vulnerable patient population.
  • Increased awareness and implementation of galactomannan testing could improve the diagnosis and management of IPA in severe influenza.
  • Further research is needed to understand barriers to galactomannan testing adoption.